Perbedaan Merck Tbk. dan Sarana Mitra Luas Tbk.: Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb), sedangkan Sarana Mitra Luas Tbk. diperdagangkan di Rp318 (kapitalisasi pasar 2,77 T, volume 24 jam 21,89 jt). Perbedaan utamanya: Sarana Mitra Luas Tbk. lebih besar dari sisi kapitalisasi pasar, dan Sarana Mitra Luas Tbk. lebih aktif diperdagangkan (21,89 jt vs 37,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MERK | SMIL | |
|---|---|---|
Kapitalisasi Pasar | 1,7 T | 2,77 T |
Volume | 37,6 rb | 21,89 jt |
Lot | 376 | 218,92 rb |
Perputaran | 144,47 jt | 6,89 M |
Harga Rata-rata | 3.842,23 | 314,64 |
Nilai Transaksi | 144,47 jt | 6,89 M |
Harga Ekuilibrium Indikatif | 3.840 | 318 |
Volume Ekuilibrium Indikatif | 7 | 11,02 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →PT Sarana Mitra Luas Tbk (the Company) was established on Sep 28, 2006 based on Notarial Deed No. 06 of Fransiska Bonita Maya Dwi Tanti, S.H., notary in Bekasi. The Company started its commercial operations in 2006.
Selengkapnya di halaman SMIL →